Table 1. Mutational status of human lung cancer cell lines.
Cell line | Histology | EGFR | KRAS | ALK | BRAF | MET | RET | ROS1 | ERBB2 | PTEN | |
---|---|---|---|---|---|---|---|---|---|---|---|
PD-L1 high | NCI-H1373 | Ad | wt | G12C | p.E1435dela | wt | wt | wt | wt | wt | wt |
NCI-H441 | Ad | wt | G12V | wt | wt | wt | wt | wt | wt | wt | |
NCI-H647 | Ad | wt | G13D | wt | wt | wt | wt | wt | wt | wt | |
NCI-H1650 | Ad | p.ELREA746del | wt | wt | wt | wt | wt | wt | wt | wt | |
NCI-H358 | Ad | wt | G12C | wt | wt | wt | wt | wt | wt | wt | |
NCI-H1975 | Ad | L858R, T790M | wt | wt | wt | wt | wt | wt | wt | wt | |
NCI-H226 | Sq | wt | wt | wt | wt | wt | wt | wt | wt | wt | |
SK-MES-1 | Sq | wt | wt | wt | wt | wt | wt | wt | wt | wt | |
EBC-1 | Sq | wt | wt | wt | wt | wt | wt | wt | wt | wt | |
NCI-H460 | La | wt | Q61Hb | wt | wt | wt | wt | wt | wt | wt | |
PD-L1 low | SK-LU-1 | Ad | wt | G12D | wt | wt | wt | wt | wt | wt | wt |
VMRC-LCD | Ad | wt | wt | wt | wt | wt | wt | wt | wt | wt | |
ABC-1 | Ad | wt | wt | wt | wt | wt | wt | wt | wt | wt | |
RERF-LC-MS | Ad | wt | wt | wt | wt | wt | wt | wt | wt | wt | |
NCI-H23 | Ad | wt | G12C | wt | wt | wt | R77Lc | wt | wt | wt | |
NCI-H522 | Ad | wt | wt | wt | wt | wt | wt | wt | wt | wt | |
NCI-H2170 | Sq | wt | wt | wt | wt | wt | wt | wt | wt | wt | |
LK-2 | Sq | wt | wt | wt | wt | wt | wt | wt | wt | wt | |
SBC-5 | SCLC | wt | wt | wt | wt | wt | wt | wt | S1050Le | wt | |
DMS114 | SCLC | wt | wt | wt | wt | wt | wt | T870Nd | wt | wt |
wt: wild type
a, E1435 resides downstream of the tyrosine kinase domain (1116–1383) of ALK; its significance is unknown.
b, Q61H is a minor mutation in exon 3 of KRAS.
c, R77L of RET is located at the N-terminus; its significance is unknown.
d, T870N of ROS1 resides outside any known motifs; its significance is unknown.
e, S1050L of ERBB2 resides near the Tyr1054 residue downstream of the tyrosine kinase domain; its significance is unknown.